David A. Melnick

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Tamara Joseph, Attorney-in-Fact for David A. Melnick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David A. Melnick:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Chief Medical Officer Common Stock 62,081 $78,843 $1.27 01 Feb 2022 Direct
Spero Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 53,190 $59,573 $1.12 01 Feb 2022 Direct

Insider Reports Filed by David A. Melnick

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRO Spero Therapeutics, Inc. 01 Feb 2022 2 $0 4 Chief Medical Officer 03 Feb 2022, 15:19
SPRO Spero Therapeutics, Inc. 26 Aug 2021 1 $0 4 Chief Medical Officer 30 Aug 2021, 16:15